National Medical Care Company announced that with reference to the results of Ordinary General Assembly Meeting held on Tuesday September 6, 2022, which included the election of a board of directors for the new term starting on September 15, 2022 for three years which expires on September 14, 2025. The national medical company announced the decision of the board of Directors at its first meeting of the new board on September 15, 2022, which includes the appointment of the Chairman of the Board of Directors, the Vice-President, the managing Director, the secretary, and the formation of committees, as follows: First: The Council decided to appoint: Mr. Saad bin Abdulmohsen Al-Fadly (Chairman of the Board of Directors); Mr. Michael Davis (Vice Chairman); Dr. Abdulaziz bin Saleh Al-Obaid (Managing Director); Second: The company's representatives have been appointed to the Capital Market Authority, and they are: Mr. Saad bin Abdulmohsen Al-Fadly; and Dr. Abdulaziz bin Saleh Al-Obaid. Third: A Secretary to the Board of Directors has been appointed Mr.Adel Attallah AlJabrti.

Fourth: Formation of the Executive Committee from the following members: Mr. Ahmed bin Wazaa Al-Qahtani; Mr. Michael Davis; Dr. Abdulaziz bin Saleh Al-Obaid; Mr. Sami bin Suliman Al-Khashan. Fifth: Formation of the Nominations and Remunerations Committee from the following members: Mr. Saad bin Abdulmohsen Al-Fadly; Mr. Bashar bin Abdulaziz AbalKhail; Mr. Mai Bint Muhammad Al-Hoshan; Mr. Badr bin Fahad Al-Athel.